Summary Blackrock Microsystems, LLC (Blackrock) is a medical device company that designs and sells tools for neuroscience. The company's products include electrodes, behavioral systems, headstages, data simulation systems, data acquisition systems, adapters, video system and analysis software. Its data acquisition products include NeuroPort-human, Cerebus-animal, and CerePlex direct-small animal. Blackrock's electrodes include microelectrode arrays, Utah array, array inserter and surgical training. The company provides tools for neural engineering and neuroprosthetics research and clinical community. It serves pharma development, healthcare and personalized medicine sectors. The company operates in Germany, China, Japan, Taiwan, Singapore, India, and South Korea. Blackrock is headquartered in Salt Lake, Utah, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Blackrock Microsystems, LLC - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Blackrock Microsystems, LLC Company Snapshot 5 Blackrock Microsystems, LLC Company Overview 5 Blackrock Microsystems, LLC Pipeline Products and Clinical Trials Overview 6 Blackrock Microsystems, LLC- Pipeline Analysis Overview 8 Key Facts 8 Blackrock Microsystems, LLC - Major Products and Services 9 Blackrock Microsystems, LLC Pipeline Products by Development Stage 10 Blackrock Microsystems, LLC Clinical Trials by Trial Status 11 Blackrock Microsystems, LLC Pipeline Products Overview 12 Andara OFS Plus 12 Andara OFS Plus Product Overview 12 Andara Oscillating Field Stimulator system 13 Andara Oscillating Field Stimulator system Product Overview 13 BrainGate Neural Interface System 14 BrainGate Neural Interface System Product Overview 14 BrainGate2 Neural Interface System 15 BrainGate2 Neural Interface System Product Overview 15 BrainGate2 Neural Interface System Clinical Trial 16 Blackrock Microsystems, LLC - Key Competitors 17 Blackrock Microsystems, LLC - Key Employees 18 Blackrock Microsystems, LLC - Locations And Subsidiaries 19 Head Office 19 Recent Developments 20 Blackrock Microsystems, LLC, Recent Developments 20 Dec 03, 2014: New European Headquarters to Propel Blackrock Microsystems' Growth, Neuroscience Research 20 Nov 13, 2014: Blackrock Microsystems Showcases Wireless Brain-Interface at Society for Neuroscience Conference 20 Nov 05, 2014: Blackrock Microsystems Initiates Two Industry Partnerships that Empower Neuroscience Research 21 Sep 24, 2008: Cyberkinetics Neurotechnology Systems Enters Into Manufacturing Agreement with I2S Micro Implantable Systems For NeuroPort System 21 Mar 03, 2008: Cyberkinetics Andara OFS Therapy Featured In Presentations at the AANS/CNS Meeting 22 Dec 11, 2007: Cyberkinetics Receives FDA Response Letter On Andara OFS System For Acute Spinal Cord Injury 22 Jul 17, 2007: Cyberkinetics' BrainGate Technology Wins Prestigious ''R&D 100'' Award 22 Jun 19, 2007: One Of First Patients To Be Implanted With Cyberkinetics' Andara OFS System For Spinal Cord Injury To Meet With Members Of Congress 23 Jun 05, 2007: Cyberkinetics Announces United States Patent And Trademark Office Issuance Of Patent For Brain Implant System 23 Apr 11, 2007: United States Patent And Trademark Office Issues Cyberkinetics Patent For Andara OFS Therapy 23 Appendix 24 Methodology 24 About GlobalData 24 Contact Us 24 Disclaimer 24
List of Tables
Blackrock Microsystems, LLC Pipeline Products and Clinical Trials Overview 6 Blackrock Microsystems, LLC Pipeline Products by Equipment Type 6 Blackrock Microsystems, LLC Pipeline Products by Indication 7 Blackrock Microsystems, LLC Clinical Trials by Trial Status 7 Blackrock Microsystems, LLC, Key Facts 8 Blackrock Microsystems, LLC, Major Products and Services 9 Blackrock Microsystems, LLC Number of Pipeline Products by Development Stage 10 Blackrock Microsystems, LLC Pipeline Products Summary by Development Stage 10 Blackrock Microsystems, LLC Clinical Trials by Trial Status 11 Blackrock Microsystems, LLC Clinical Trials Summary 11 Andara OFS Plus - Product Status 12 Andara OFS Plus - Product Description 12 Andara Oscillating Field Stimulator system - Product Status 13 Andara Oscillating Field Stimulator system - Product Description 13 BrainGate Neural Interface System - Product Status 14 BrainGate Neural Interface System - Product Description 14 BrainGate2 Neural Interface System - Product Status 15 BrainGate2 Neural Interface System - Product Description 15 BrainGate2 Neural Interface System - Feasibility Study of an Intracortical Neural Interface System for Persons with Tetraplegia: BrainGate2 16 lackrock Microsystems, LLC, Key Employees 18
List of Figures
Blackrock Microsystems, LLC Pipeline Products by Equipment Type 7 Blackrock Microsystems, LLC Pipeline Products by Development Stage 10 Blackrock Microsystems, LLC Clinical Trials by Trial Status 11
Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast periodRead More...
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to moRead More...
Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expeRead More...
Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving creamRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.